| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 |
| filingDate |
2014-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18c52ce92bb1bf838005eb8298c38ec4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fed1697029811b30610d753fba6c47a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c91321b0cda079361b17505dea9c007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b89f7065c33446f91b997668f1b44d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e9bd80a489d255a79bead1bab4daeab |
| publicationDate |
2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160034983-A |
| titleOfInvention |
Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
| abstract |
The present invention relates to a fixed dose oral pharmaceutical composition for use in the treatment of tuberculosis, and a method of preparing the same, wherein the oral pharmaceutical composition comprises a) granules comprising isoniazid and one or more granular excipients, b) A granulate comprising lipapentin and one or more intragranular excipients, and c) one or more extragranular excipients. |
| priorityDate |
2013-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |